Spencer Osborne
Contributor since: 2007
Company: SiriusBuzz Premium
Latest Articles
MannKind - Scripts, Advertising, And Cash
Youngevity Makes Important Move In Hemp And CBD Sector
MannKind - Afrezza Scripts, Advertising, Insurance, And Cash
MannKind Closes Out January With Modest Afrezza Sales - Ads Ramp Up
Shareholders Of Pandora Approve Sirius XM Takeover - Next Steps For Investors
Youngevity Making Important Moves In Coffee Sector
Arena's Deal With United Therapeutics Passes Regulatory Hurdle
MannKind: Perspective On Marketing Efforts
MannKind Announces Direct Purchase Program For Afrezza - What Investors Should Know
MannKind: Afrezza Scripts Start 2019 Modestly
Youngevity Inks Deal With Icelandic Water Holdings - It's Just The Tip Of The Iceberg
SiriusXM Teams Up With Visa As Company Beats 2018 Guidance And Issues 2019 Guidance
MannKind In 2019: Can Afrezza Deliver, Or Is Pipeline The Key?
MannKind - Afrezza Scripts Jump As Secondary Funding Sources Become Known
Youngevity: Why Passage Of The 2018 Farm Bill Is Important Catalyst
KemPharm Delay In Partnership May Have Silver Lining
MannKind: Afrezza Scripts Down, Sharecount Up, And Shareholders Have Questions
MannKind Drops On Proposed Share Offering - What Investors Should Know
MannKind  - Afrezza Scripts Hit Milestone As 2018 Comes To A Close
MannKind: Afrezza Scripts Take Expected Holiday Dip - The Good And The Bad
MannKind: Afrezza Script Growth Remains Slower Than Desired
What Does United Therapeutics' Most Recent Deal Mean To MannKind?
Arena Inks $1.2 Billion Deal With United Therapeutics
Youngevity Shows Q3 Improvement In The Right Places Despite Q3 Loss
MannKind - Afrezza Scripts Flat As Company Gets Into Home Stretch On 2018
Arena Pharmaceuticals Posts Q3 Loss But Pipeline Is Center Stage
Playing The Sirius XM-Pandora Merger
MannKind: Where Is This Company Headed?
MannKind Quarterly Call Hits And Misses
KemPharm Inks Deal On Apadaz - Stock Rebounds
Youngevity Makes Move To Clean Up Balance Sheet
MannKind: Scripts, Cash, And Quarterly Calls